Engineers using their expertise to address global health crisis, showcasing problem-solving skills beyond their field.
-
Dr. Philip McMillan introduces engineers Wakim and Prakash from Germany and India, respectively. • 1:29
-
Wakim, a retired businessman, delves into the connection between chronic illnesses and environmental factors. • 3:30
-
Prakash, with 25 years of engineering experience, highlights the engineer’s role in finding solutions for mankind’s problems. • 4:49
-
The engineers met through philanthropic projects focusing on sustainability and energy technology. • 6:34
-
Their collaboration on COVID-19 project stemmed from their shared interest in solving complex problems. • 6:43
-
They initially planned to work on sustainability projects but shifted focus to COVID-19 intervention. • 7:00
-
Wakim’s background in industrial supply involved optimizing processes in car manufacturing, like at Porsche and Volkswagen. • 7:13
-
Their diverse expertise and shared passion for problem-solving led to their impactful collaboration. • 8:03
Engineers united to combat COVID-19 through innovative solutions and teamwork.
-
Engineers retired from business to focus on COVID-19 solutions • 8:22
-
Started by identifying the main protease of the virus • 10:19
-
Utilized research on SARS and MERS for insights on combating the virus • 11:30
-
Took a military approach of defending, attacking, and repairing in the fight against COVID-19 • 14:14
-
Formulated a unique medication with nine molecules to combat the virus • 14:28
Innovative approach using engineering principles to tackle COVID-19 challenges.
-
Utilized nutraceutical approach due to time constraints and safety requirements. • 14:58
-
Filtered out 8,000 compounds to focus on top priority pathways using AI technology. • 17:31
-
Confidence in success driven by diverse team and mindset of tackling challenges head-on. • 19:48
-
Approached COVID-19 as an opportunity to innovate and make a significant impact. • 20:03
Innovative engineers collaborate to develop a liquid suspension for COVID-19 treatment.
-
The drug target pathway was established after 6-8 weeks of development. • 21:18
-
Muscle activation was a key point in the drug target pathway. • 22:02
-
The product is a suspension with 9 ingredients for increased bioavailability. • 24:12
-
Suspension chosen for stability, bioavailability, and muco adhesive effect. • 25:00
-
Extensive testing and precautions taken for international shipping of the liquid product. • 25:56
-
Molecules in the product have mucous adhesive effect to slow down virus replication. • 26:27
-
Engineers evaluated multiple formulation options before finalizing the liquid suspension. • 27:03
Innovative approach to developing a natural solution for COVID-19 using molecules, with a focus on protease inhibitors and anti-inflammatory properties.
-
Scientific team sourcing natural molecules for COVID-19 solution without using harmful sources like shark shells. • 27:09
-
Extensive research and trials conducted to find effective formulations, with a focus on 3CR protease and organ regenerative properties. • 27:36
-
Challenges faced in finding effective supplements and formulations, leading to the development of a unique solution. • 28:01
-
Importance of understanding natural molecules’ interaction with the body and their metabolic breakdown for effective treatment. • 32:05
-
Nature’s superiority in providing molecules that are recognized by the body and have been around for millions of years, ensuring trust in natural solutions. • 33:03
In-depth analysis of clinical trials and research on a naturoceutical product for COVID-19 treatment.
-
570 in silico studies conducted for molecule evaluation. • 34:55
-
Animal trials done to ensure safety and efficacy. • 35:26
-
Clinical trials initiated in India for acute and long COVID-19 cases. • 36:14
-
Focus on biomarkers like TNF, interleukin 6, and C-reactive protein. • 37:15
-
Product shows promise in treating chronic inflammation seen in long COVID-19 cases. • 37:53
-
Monitoring patients post-acute phase to observe symptom progression. • 38:30
-
Significant data collection and comparison between treatment and control groups. • 39:24
-
Combination therapy approach with standard medications for enhanced efficacy. • 40:02
Collaboration between Ayurveda and traditional medicine in treating COVID-19 symptoms.
-
Discussion on using nutraceuticals in combination with pharmaceutical products. • 40:16
-
Research approach of breaking down products to study their effects on inflammation. • 41:00
-
Importance of settling down macrophage activation in long COVID. • 42:36
-
Recommendation to use nutraceuticals in acute phase with breaks for body recovery. • 43:57
-
Hundreds of Ayurvedic herbs and remedies tested in clinical settings for COVID-19. • 45:44
-
Consideration of synergistic effects when combining natural remedies for effectiveness. • 46:28
Innovative nutraceutical treatment for COVID-19 shows significant improvement in lung health within 12 days.
-
Nutraceutical treatment includes vitamin D3, zinc, vitamin C, and quercetin. • 46:59
-
High-quality supplements with proper bioavailability and purity are crucial for effectiveness. • 47:21
-
The nutraceutical does not require a prescription and can be purchased like other supplements. • 49:00
-
Clinical trials showed over 75% improvement in lung health after 12 days of treatment. • 51:08
-
Natural compounds are often underestimated compared to pharmaceutical drugs. • 52:42
-
Skepticism exists due to the nutraceutical nature of the treatment and lack of familiarity with the company. • 53:05
-
The formulation and production of the nutraceutical involve highly professional experts and top companies in the industry. • 53:36
Innovative collaboration addressing long-term health impacts of COVID-19.
-
Nutraceutical designed like a phytopharmaceutical for immune support. • 53:49
-
Skepticism faced despite product effectiveness and safety. • 54:00
-
Recommendation of vitamin C, D, and zinc for overall health since January 2020. • 54:20
-
Organic growth of product usage for immune support without marketing. • 54:46
-
Anticipation of post-pandemic immune-related health challenges. • 56:00
-
Focus on addressing intestinal inflammation and gut health for overall well-being. • 57:27
-
Differentiating treatment approach for long COVID based on pre-existing health conditions. • 59:01
-
Emphasis on gut health and probiotics in managing autoimmune diseases. • 59:42
In-depth discussion on potential treatments for COVID-19, including concerns about neurological effects of spike proteins.
-
Potential treatments for leaky gut and intestinal inflammation are being developed. • 1:00:47
-
Concerns raised about neurodegenerative problems related to spike proteins. • 1:01:37
-
Omicron variant may increase risk of neuro-inflammatory conditions due to spike protein characteristics. • 1:03:04
-
Maintain hope and confidence in overcoming the crisis with early treatment options. • 1:06:31
-
Encouragement to take COVID-19 seriously and stay informed with credible sources. • 1:07:24
Engineers discussing the importance of naturoceuticals in the fight against the pandemic.
-
Emphasized the significance of reading and learning to survive and prevail • 1:07:32
-
Urged to be smart, alert, and take things seriously in the battle against the pandemic • 1:07:39
-
Used a war analogy to highlight the importance of being careful and vigilant • 1:07:59
-
Stressed the value of listening to people, reading, and conducting personal research • 1:08:12
-
Highlighted the importance of naturoceuticals in the ongoing fight against the pandemic • 1:08:27
-
Expressed gratitude for the insightful conversation and anticipated more engaging discussions in the future • 1:08:48
-
Ended the conversation with music and appreciation for the audience • 1:09:27